Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories conformant Smelters Sourcing 3TG from DRC or Covered Countries
Form SD Specialized Disclosure Reports
Latest, FY2025
17
Period ended Dec 31, 2025
Change on a year earlier
-29.2%
24 in FY2024
History
11 years
Since FY2015
Sources
11
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Conformant Smelters Sourcing 3TG from DRC or Covered Countries | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 17 | -29.2% | SEC Filing (0001104659-26-066986) ↗ |
| FY2024 | Dec 31, 2024 | 24 | 0.0% | SEC Filing (0000001800-25-000006) ↗ |
| FY2023 | Dec 31, 2023 | 24 | +20.0% | SEC Filing (0001104659-24-066637) ↗ |
| FY2022 | Dec 31, 2022 | 20 | -9.1% | SEC Filing (0001104659-23-066523) ↗ |
| FY2021 | Dec 31, 2021 | 22 | – | SEC Filing (0001104659-22-065888) ↗ |
| FY2020 | Dec 31, 2020 | 0 | -100.0% | SEC Filing (0001104659-21-073673) ↗ |
| FY2019 | Dec 31, 2019 | 2 | -88.9% | SEC Filing (0001104659-20-067425) ↗ |
| FY2018 | Dec 31, 2018 | 18 | 0.0% | SEC Filing (0001104659-19-033008) ↗ |
| FY2017 | Dec 31, 2017 | 18 | -25.0% | SEC Filing (0001104659-18-037140) ↗ |
| FY2016 | Dec 31, 2016 | 24 | +4.3% | SEC Filing (0001104659-17-036399) ↗ |
| FY2015 | Dec 31, 2015 | 23 | – | SEC Filing (0001104659-16-124278) ↗ |
Cite this data
StockData. (2026). Abbott Laboratories Conformant Smelters Sourcing 3TG from DRC or Covered Countries, annual FY2015–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/sd-drc-src
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.